Cargando…
Imatinib in COVID-19: hope and caution
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409974/ https://www.ncbi.nlm.nih.gov/pubmed/34147143 http://dx.doi.org/10.1016/S2213-2600(21)00266-6 |
_version_ | 1783747069276585984 |
---|---|
author | Bernal-Bello, David Morales-Ortega, Alejandro Isabel Farfán-Sedano, Ana de Tena, Jaime García Martín-López, Juan Víctor San |
author_facet | Bernal-Bello, David Morales-Ortega, Alejandro Isabel Farfán-Sedano, Ana de Tena, Jaime García Martín-López, Juan Víctor San |
author_sort | Bernal-Bello, David |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8409974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84099742021-09-02 Imatinib in COVID-19: hope and caution Bernal-Bello, David Morales-Ortega, Alejandro Isabel Farfán-Sedano, Ana de Tena, Jaime García Martín-López, Juan Víctor San Lancet Respir Med Comment Elsevier Ltd. 2021-09 2021-06-18 /pmc/articles/PMC8409974/ /pubmed/34147143 http://dx.doi.org/10.1016/S2213-2600(21)00266-6 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Comment Bernal-Bello, David Morales-Ortega, Alejandro Isabel Farfán-Sedano, Ana de Tena, Jaime García Martín-López, Juan Víctor San Imatinib in COVID-19: hope and caution |
title | Imatinib in COVID-19: hope and caution |
title_full | Imatinib in COVID-19: hope and caution |
title_fullStr | Imatinib in COVID-19: hope and caution |
title_full_unstemmed | Imatinib in COVID-19: hope and caution |
title_short | Imatinib in COVID-19: hope and caution |
title_sort | imatinib in covid-19: hope and caution |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409974/ https://www.ncbi.nlm.nih.gov/pubmed/34147143 http://dx.doi.org/10.1016/S2213-2600(21)00266-6 |
work_keys_str_mv | AT bernalbellodavid imatinibincovid19hopeandcaution AT moralesortegaalejandro imatinibincovid19hopeandcaution AT isabelfarfansedanoana imatinibincovid19hopeandcaution AT detenajaimegarcia imatinibincovid19hopeandcaution AT martinlopezjuanvictorsan imatinibincovid19hopeandcaution |